Cas no 1228182-45-3 (Sulfapyridine-13C6)
Sulfapyridine-13C6 Chemical and Physical Properties
Names and Identifiers
-
- Sulfapyridine-13C6
- 4-amino-N-pyridin-2-ylbenzenesulfonamide
- Sulfapyridine-(phenyl-13C6)
- DTXSID90746824
- 4-Amino-N-pyridin-2-yl(1,2,3,4,5,6-13C6)cyclohexa-1,3,5-triene-1-sulfonamide
- 4-Amino-N-(pyridin-2-yl)(~13~C_6_)benzene-1-sulfonamide
- Sulfapyridine 13C6 (phenyl 13C6)
- Sulfapyridine-(phenyl-13C6), VETRANAL(TM), analytical standard
- 1228182-45-3
-
- MDL： MFCD16652548
- Inchi： 1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)/i4+1,5+1,6+1,7+1,9+1,10+1
- InChI Key： GECHUMIMRBOMGK-PXKSRZEUSA-N
- SMILES： S([13C]1[13CH]=[13CH][13C](=[13CH][13CH]=1)N)(NC1C=CC=CN=1)(=O)=O
Computed Properties
- Exact Mass: 255.07732679g/mol
- Monoisotopic Mass: 255.07732679g/mol
- Isotope Atom Count: 6
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 17
- Rotatable Bond Count: 3
- Complexity: 331
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0
- Topological Polar Surface Area: 93.5?2
Sulfapyridine-13C6 Security Information
- Hazardous Material transportation number：NONH for all modes of transport
- WGK Germany：2
Sulfapyridine-13C6 Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | 32547-10MG |
Sulfapyridine-13C6 |
1228182-45-3 | 10mg |
￥5624.01 | 2025-02-18 | ||
| XI GE MA AO DE LI QI （ SHANG HAI ） MAO YI Co., Ltd. | 32547-10MG |
1228182-45-3 | 10MG |
￥5049.2 | 2025-02-18 | |||
| A2B Chem LLC | AE63354-25mg |
Sulfapyridine-13C6 |
1228182-45-3 | 25mg |
$771.00 | 2024-04-20 | ||
| A2B Chem LLC | AE63354-50mg |
Sulfapyridine-13C6 |
1228182-45-3 | 50mg |
$1282.00 | 2024-04-20 |
Sulfapyridine-13C6 Suppliers
Audited Supplier
Sulfapyridine-13C6 Related Literature
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
-
Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
Additional information on Sulfapyridine-13C6
Recent Advances in Sulfapyridine-13C6 Research and Its Applications in Chemical Biology and Medicine
In recent years, the compound with CAS number 1228182-45-3 and its isotopically labeled counterpart, Sulfapyridine-13C6, have garnered significant attention in the field of chemical biology and pharmaceutical research. Sulfapyridine-13C6, a stable isotope-labeled analog of sulfapyridine, is increasingly utilized in metabolic studies, drug development, and analytical chemistry due to its unique properties. This research brief aims to synthesize the latest findings related to these compounds, highlighting their applications, mechanisms, and potential therapeutic benefits.
The primary focus of recent studies has been on the pharmacokinetic and pharmacodynamic properties of Sulfapyridine-13C6. Researchers have employed advanced techniques such as liquid chromatography-tandem mass spectrometry (LC-MS/MS) to track the metabolic pathways of this compound in biological systems. These studies have revealed that Sulfapyridine-13C6 serves as an excellent internal standard for quantifying sulfapyridine and its metabolites in complex matrices, thereby enhancing the accuracy of bioanalytical assays.
Another critical area of investigation involves the role of Sulfapyridine-13C6 in understanding drug-drug interactions. Recent publications have demonstrated its utility in elucidating the mechanisms by which sulfapyridine interacts with other pharmaceuticals, particularly in the context of antimicrobial therapy. The isotope labeling allows for precise tracking of the parent compound and its metabolites, providing insights into potential synergistic or antagonistic effects when co-administered with other drugs.
Furthermore, the compound with CAS 1228182-45-3 has been explored for its potential applications in targeted drug delivery systems. Preliminary studies suggest that modifications to its chemical structure could enhance its bioavailability and tissue specificity. These findings open new avenues for the development of next-generation sulfonamide-based therapeutics with improved efficacy and reduced side effects.
In conclusion, the ongoing research on Sulfapyridine-13C6 and related compounds underscores their importance in advancing our understanding of drug metabolism and interaction. The integration of isotopic labeling techniques with cutting-edge analytical methods continues to provide valuable data that can inform clinical practice and drug development. Future studies are expected to further explore the therapeutic potential of these compounds, particularly in personalized medicine and precision oncology.
1228182-45-3 (Sulfapyridine-13C6) Related Products
- 144-83-2(Sulfapyridine)
- 24342-38-9(Silver,(4-amino-N-2-pyridinylbenzenesulfonamidato-NN,O)- (9CI))
- 127-57-1(Benzenesulfonamide,4-amino-N-2-pyridinyl-, sodium salt (1:1))
- 52776-76-8(4-Methyl-N-pyridin-2-yl-benzenesulfonamide)
- 89257-24-9(1-Naphthalenesulfonamide, N-2-pyridinyl-)
- 83608-12-2(Dichloroplatinum(2+); [4-(pyridin-2-ylsulfamoyl)phenyl]azanide)
- 57198-81-9(Benzenediazonium, 4-[(2-pyridinylamino)sulfonyl]-, chloride)
- 83608-13-3(Platinum,bis(4-amino-N-2-pyridinylbenzenesulfonamide-N4)diiodo-, (SP-4-2)- (9CI))
- 1212-07-3(Benzenesulfonamide,N-2-pyridinyl-)
- 1189863-86-2(Sulfapyridine-d)
